Request Trial
jugulator-shutterstock-com-question-mark-
jugulator / Shutterstock.com
6 September 2016EuropeChristopher Stothers and Paul Abbott

SPCs and the unitary patent system: what now?

In December last year we wrote an article discussing the complexities surrounding the application of supplementary protection certificates (SPCs) to the unitary patent system. Since then the UK has voted in a referendum to leave the EU, but for now the UK remains a member of the EU, with all the rights and responsibilities that entails.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
UPC upholds injunction in Invisalign maker’s software dispute with rival
9 July 2026   China-headquartered Angelalign failed to convince UPC appellate judges to overturn a ban that affects its ability to offer orthodontic planning software in Europe with certain functionality.
Europe
BioNTech and Pfizer secure big European win over mRNA patent
8 July 2026   UPC judges revoke a patent asserted against the companies over their Comirnaty COVID-19 vaccine, in a ruling that clarified the court’s key principles on exclusive licences, novelty and inventive step.
Europe
UPC revives patent, but timing sinks Guardant’s appeal
6 July 2026   The Unified Patent Court delivers a mixed ruling in a dispute over liquid biopsy technology, overturning a finding that a patent was likely invalid while refusing to grant interim relief because of the patent owner’s delay.


Editor's picks

What’s at stake in Australia’s biggest pharma patent appeal in years?
Pharma
What’s at stake in Australia’s biggest pharma patent appeal in years?
1 July 2026

Editor's picks

Pharma
What’s at stake in Australia’s biggest pharma patent appeal in years?
1 July 2026

More features

UPC upholds injunction in Invisalign maker’s software dispute with rival
BioNTech and Pfizer secure big European win over mRNA patent
Pillsbury nabs ‘veteran’ IP litigator and trial lawyer from Goodwin
UPC revives patent, but timing sinks Guardant’s appeal
China’s medtech shake-up forces rethink on pricing, IP and innovation
HGF expands European offering with pair of in-house hires
King & Spalding continues hiring spree from pre-merged Winston
Merck KGaA agrees $11.3bn deal in major life sciences expansion